ATE462431T1 - Verwendung von furanalkylen zur herstellung eines arzneimittels für die behandlung von adipositas sowie kosmetische behandlung von übergewicht - Google Patents
Verwendung von furanalkylen zur herstellung eines arzneimittels für die behandlung von adipositas sowie kosmetische behandlung von übergewichtInfo
- Publication number
- ATE462431T1 ATE462431T1 AT05773033T AT05773033T ATE462431T1 AT E462431 T1 ATE462431 T1 AT E462431T1 AT 05773033 T AT05773033 T AT 05773033T AT 05773033 T AT05773033 T AT 05773033T AT E462431 T1 ATE462431 T1 AT E462431T1
- Authority
- AT
- Austria
- Prior art keywords
- obesity
- treatment
- radical
- furanalkylene
- production
- Prior art date
Links
- 208000008589 Obesity Diseases 0.000 title abstract 3
- 235000020824 obesity Nutrition 0.000 title abstract 3
- 239000002537 cosmetic Substances 0.000 title 1
- 229940126601 medicinal product Drugs 0.000 title 1
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 abstract 3
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 2
- 206010033307 Overweight Diseases 0.000 abstract 1
- 125000000217 alkyl group Chemical group 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 229940079593 drug Drugs 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
- A61K31/341—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide not condensed with another ring, e.g. ranitidine, furosemide, bufetolol, muscarine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/4973—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/06—Preparations for care of the skin for countering cellulitis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Dermatology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Birds (AREA)
- Child & Adolescent Psychology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Cosmetics (AREA)
- Medicines Containing Plant Substances (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Furan Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0405782A FR2870742B1 (fr) | 2004-05-28 | 2004-05-28 | Utilisation d'alkyle furannes pour la preparation d'un medicament destine au traitement du diabete, de l'obesite et pour le traitement cosmetique de la cellulite et de la surcharge ponderale |
FR0502758A FR2870743B1 (fr) | 2005-03-21 | 2005-03-21 | Utilisation d'alkyle furannes pour la preparation d'un medicament destine au traitement de l'obesite et pour le traitement cosmetique de la surcharge ponderale |
PCT/FR2005/001312 WO2005117857A1 (fr) | 2004-05-28 | 2005-05-27 | Utilisation d’alkyle furannes pour la preparation d'un medicament destine au traitement de l’obesite et pour le traitement cosmetique de la surcharge ponderale |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE462431T1 true ATE462431T1 (de) | 2010-04-15 |
Family
ID=34978848
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT05773033T ATE462431T1 (de) | 2004-05-28 | 2005-05-27 | Verwendung von furanalkylen zur herstellung eines arzneimittels für die behandlung von adipositas sowie kosmetische behandlung von übergewicht |
Country Status (11)
Country | Link |
---|---|
US (1) | US7589121B2 (de) |
EP (1) | EP1750695B1 (de) |
JP (2) | JP4842260B2 (de) |
AT (1) | ATE462431T1 (de) |
CA (1) | CA2567479C (de) |
DE (1) | DE602005020274D1 (de) |
ES (1) | ES2340510T3 (de) |
HK (1) | HK1100279A1 (de) |
MX (1) | MXPA06013885A (de) |
PL (1) | PL1750695T3 (de) |
WO (1) | WO2005117857A1 (de) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2340510T3 (es) * | 2004-05-28 | 2010-06-04 | Laboratoires Expanscience | Uso de alquil-furanos para la preparacion de un medicamento destinado al tratamiento de la obesidad y para el tratamiento cosmetico del exceeso de peso. |
FR2870742B1 (fr) * | 2004-05-28 | 2008-03-14 | Expanscience Laboratoires Sa | Utilisation d'alkyle furannes pour la preparation d'un medicament destine au traitement du diabete, de l'obesite et pour le traitement cosmetique de la cellulite et de la surcharge ponderale |
FR2889956B1 (fr) * | 2005-08-30 | 2012-04-20 | Expanscience Lab | Utilisation d'au moins un 2-alkyle furane, a titre de principe actif depigmentant ou eclaircissant |
WO2010026596A2 (en) * | 2008-09-08 | 2010-03-11 | Shai Meretzki | Compositions comprising polyhydroxyltate fatty alcohol derivatives and the therapeutic uses |
US20110250154A1 (en) * | 2008-09-08 | 2011-10-13 | Shai Meretzki | Cosmetic compositions comprising polyhydroxyltate fatty alcohols and derivatives and uses thereof |
WO2010065528A2 (en) * | 2008-12-02 | 2010-06-10 | Kreations By Kristin, L.C. | Gymnema-containing lip balm compositions and associated methods |
FR2949044B1 (fr) * | 2009-08-12 | 2021-05-07 | Expanscience Lab | Composition comprenant une fraction d'insaponifiable |
JP5818300B2 (ja) * | 2010-12-27 | 2015-11-18 | 雪印メグミルク株式会社 | ミルクセラミド含有食品及びその製造方法 |
EP2978422A4 (de) | 2013-03-29 | 2017-04-05 | Avoscience, LLC | Lipidfuran-, pyrrol- und thiophenverbindungen zur behandlung von krebs, neurologischen erkrankungen und fibrotischen erkrankungen |
US20170173056A1 (en) * | 2014-03-20 | 2017-06-22 | Cheryl Lee Eberting | Compositions for the treatment of dermatological diseases and disorders |
WO2017189865A1 (en) | 2016-04-27 | 2017-11-02 | Avoscience, Llc | Lipidic furan, pyrrole, and thiophene compounds for use in the treatment of atrophic vaginitis |
Family Cites Families (25)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4127592A (en) | 1977-03-31 | 1978-11-28 | Polak's Frutal Works, B.V. | Process of the preparation of hydroxyfurenones |
CA1169431A (en) | 1980-08-27 | 1984-06-19 | Roger A. Parker | Acylated furanyl and thienyl acrylic acids |
DE3372252D1 (en) | 1982-10-29 | 1987-07-30 | Plessey Overseas | Conductive gaskets |
FR2678632B1 (fr) | 1991-07-03 | 1994-09-02 | Pharmascience Lab | Procede de preparation de l'insaponifiable d'avocat permettant d'ameliorer sa teneur en l'une de ses fractions dite h. |
FR2678614A1 (fr) | 1991-07-03 | 1993-01-08 | Pharmascience Lab | Compose presentant une activite en tant qu'inhibiteur de la collagenase et medicament le contenant. |
US5468490A (en) | 1993-10-25 | 1995-11-21 | Conkle & Olesten | Lipidic furans useful for skin therapeutics |
JPH08332061A (ja) * | 1995-06-07 | 1996-12-17 | Sanki Shoji Kk | アボカド葉茶とその飲料及び抽出液乾固物 |
US6030993A (en) | 1996-07-02 | 2000-02-29 | Sang Sup Jew | 2-hydroxypropionic acid derivative and its manufacturing method |
JP4047441B2 (ja) * | 1998-03-05 | 2008-02-13 | 株式会社資生堂 | 脂質分解促進剤および痩身用皮膚外用剤 |
JP2000144170A (ja) * | 1998-09-01 | 2000-05-26 | Janifu Tekku:Kk | 抗肥満及び内臓蓄積脂肪低減化機能を有する物質、及びその用途 |
DE19901502C1 (de) | 1999-01-11 | 2000-09-21 | Michael Schneider | Anticellulitiszusammensetzung und ihre Verwendung |
FR2798667B1 (fr) | 1999-09-22 | 2001-12-21 | Pharmascience Lab | Procede d'extraction des composes furaniques et alcools gras polyhydroxyles de l'avocat, composition a base de et utilisation de ces composes en therapeutique, cosmetique et alimentaire |
JP4693964B2 (ja) * | 2000-08-07 | 2011-06-01 | カゴメ株式会社 | 新規摂食抑制剤 |
JP2002212177A (ja) * | 2000-11-14 | 2002-07-31 | Takeda Chem Ind Ltd | 脂質代謝改善剤 |
CN101596191B (zh) * | 2001-01-26 | 2011-06-15 | 中外制药株式会社 | 用作代谢调节剂的丙二酰基辅酶a脱羧酶抑制剂 |
US20030120073A1 (en) * | 2001-04-25 | 2003-06-26 | Seto Christopher T. | Alpha-ketocarboxylic acid based inhibitors of phosphoryl tyrosine phosphatases |
JP2005232005A (ja) | 2001-07-02 | 2005-09-02 | Maruha Corp | 新規脂肪族化合物、合成方法、利用方法 |
WO2003007888A2 (en) | 2001-07-20 | 2003-01-30 | Adipogenix, Inc. | Fat accumulation-modulating compounds |
US20040033506A1 (en) | 2001-11-30 | 2004-02-19 | Dennis Farrelly | Polynucleotides encoding novel human mitochondrial and microsomal glycerol-3-phosphate acyl-transferases and variants thereof |
FR2841470B1 (fr) * | 2002-06-27 | 2006-01-13 | Pharmascience Lab | Utilisation d'isoflavones pour la preparation de compositions topiques utiles pour favoriser l'amincissement et methode de traitement cosmetique associee |
WO2004016106A1 (fr) | 2002-07-29 | 2004-02-26 | Laboratoires Expanscience | Procede d'obtention d'un insaponifiable d'avocat riche en lipides furaniques |
US6793946B2 (en) * | 2002-07-31 | 2004-09-21 | Access Business Group International Llc. | Composition and method for lowering cholesterol |
FR2856294B1 (fr) * | 2003-06-18 | 2005-08-05 | Expanscience Lab | Utilisation cosmetique d'une composition comprenant au moins une oxazoline, a titre de principe actif, comme amincissant et/ou pour prevenir et/ou traiter la cellulite |
US20050048144A1 (en) | 2003-08-29 | 2005-03-03 | Xiao-Qing Han | Herb extract-based cosmeceutical cream for controlling the blood sugar level of diabetes and methods for making it |
ES2340510T3 (es) * | 2004-05-28 | 2010-06-04 | Laboratoires Expanscience | Uso de alquil-furanos para la preparacion de un medicamento destinado al tratamiento de la obesidad y para el tratamiento cosmetico del exceeso de peso. |
-
2005
- 2005-05-27 ES ES05773033T patent/ES2340510T3/es active Active
- 2005-05-27 JP JP2007514019A patent/JP4842260B2/ja not_active Expired - Fee Related
- 2005-05-27 PL PL05773033T patent/PL1750695T3/pl unknown
- 2005-05-27 MX MXPA06013885A patent/MXPA06013885A/es active IP Right Grant
- 2005-05-27 CA CA2567479A patent/CA2567479C/fr not_active Expired - Fee Related
- 2005-05-27 WO PCT/FR2005/001312 patent/WO2005117857A1/fr not_active Application Discontinuation
- 2005-05-27 EP EP05773033A patent/EP1750695B1/de active Active
- 2005-05-27 US US11/597,634 patent/US7589121B2/en active Active
- 2005-05-27 DE DE602005020274T patent/DE602005020274D1/de active Active
- 2005-05-27 AT AT05773033T patent/ATE462431T1/de not_active IP Right Cessation
-
2007
- 2007-07-31 HK HK07108349.4A patent/HK1100279A1/xx not_active IP Right Cessation
-
2011
- 2011-06-17 JP JP2011135366A patent/JP5405528B2/ja not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
JP4842260B2 (ja) | 2011-12-21 |
ES2340510T3 (es) | 2010-06-04 |
EP1750695A1 (de) | 2007-02-14 |
US20070238777A1 (en) | 2007-10-11 |
PL1750695T3 (pl) | 2010-08-31 |
EP1750695B1 (de) | 2010-03-31 |
CA2567479A1 (fr) | 2005-12-15 |
CA2567479C (fr) | 2012-09-11 |
MXPA06013885A (es) | 2007-01-26 |
JP2008501004A (ja) | 2008-01-17 |
WO2005117857A1 (fr) | 2005-12-15 |
US7589121B2 (en) | 2009-09-15 |
JP2012006924A (ja) | 2012-01-12 |
JP5405528B2 (ja) | 2014-02-05 |
HK1100279A1 (en) | 2007-09-14 |
DE602005020274D1 (de) | 2010-05-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE462431T1 (de) | Verwendung von furanalkylen zur herstellung eines arzneimittels für die behandlung von adipositas sowie kosmetische behandlung von übergewicht | |
DE602004024880D1 (de) | Azetidincarboxamid-derivate zur verwendung zur behandlung von cb1-rezeptor-vermittelten krankheiten | |
DE69602424D1 (de) | Verwendung von carbazolverbindungen zur herstellung eines arzneimittels für die behandlung von kongestivem herzversagen | |
BR0014649A (pt) | Utilização de um produto, medicamento, composto e composição farmacêutica | |
FI930991A (fi) | Polymerer som innehaoller diesterenheter | |
DK1268416T3 (da) | 2-alkyliden-19-nor-vitamin-D-forbindelser og deres terapeutiske anvendelser | |
HK1055117A1 (en) | 8,8A-dihydro-indenoÄ11,2-dÜthiazole derivatives, amethod for their production and their use as medi caments. | |
ATE268752T1 (de) | Aralkyl-1,2-diaminen mit calcimimetischer wirkung und verfahren zu ihrer herstellung | |
DE69432973D1 (de) | Verwendung von thiazolidindionen zur behandlung von atherosklerose und essstörungen | |
ATE267597T1 (de) | Verwendung von polycyclischen 2-amino-thiazol systemen zur herstellung von medikamenten zur prophylaxe oder behandlung von obesitas | |
CA2708538A1 (en) | Topical compositions containing desthiobiotin and its derivatives and a method of treating skin | |
DE602005027563D1 (de) | Verwendung von furanalkylen zur kosmetischen behandlung von zellulitis | |
IL166057A0 (en) | Urea-substituted and urethane-substituted acylureas methods for the production thereof and their useas medicaments | |
ATE273006T1 (de) | Verwendung von polyzyklischen thiazol-systemen zur herstellung von medikamenten zur prophylaxe oder behandlung von obesitas | |
DE50014850D1 (de) | Verwendung von bissulfonamiden zur herstellung von medikamenten zur prophylaxe oder behandlung von hyperlipidämie | |
MA32976B1 (fr) | Derives de 2-pyridin-2-yl-pyrazol-3(2h)-one, leur preparation et leur application en therapeutique comme activateurs de hif | |
HUP9904210A2 (hu) | Kamptotecin-analógok, alkalmazásuk gyógyszerként és ilyen vegyületeket tartalmazó gyógyászati készítmények | |
ATE457305T1 (de) | Neue 3-phenylpropionsäurederivate zur behandlung von diabetes | |
MA27649A1 (fr) | Derives d'acylphenyluree substitues par carbonylamino, methode de production et d'utilisation de ceux-ci. | |
DE69518706D1 (de) | Verwendung von Diphenylethanderivaten zur Herstellung eines Arzneimittels zur Behandlung von Glaukom | |
MXPA05004845A (es) | N-oxidos y derivados de melfalan para el tratamiento de estados de enfermedad asociados a un factor inducible por hipoxia. | |
ATE492285T1 (de) | Verwendung von kahalalide verbindungen zur herstellung eines arzneimittels zur behandlung von psoriasis | |
TW200505420A (en) | Fluorocombretastatin and derivatives thereof | |
HUP0105420A2 (hu) | Bulímia nervosa kezelésére szolgáló antikonvulzív származékok | |
ATE308321T1 (de) | Verwendung von c2-substituierten indan-1-ol- systemen zur herstellung von medikamenten zur prophylaxe oder behandlung von obesitas |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |